| Outgoing Relation(s) |
| vascular endothelial growth factor receptor antagonist (CHEBI:65207) is a antagonist (CHEBI:48706) |
| Incoming Relation(s) |
| axitinib (CHEBI:66910) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| DMH4 (CHEBI:229963) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| E-3810 (CHEBI:65138) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| E-3810 free base (CHEBI:65209) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| foretinib (CHEBI:91418) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| fruquintinib (CHEBI:229221) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| lenvatinib (CHEBI:85994) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| lenvatinib mesylate (CHEBI:85995) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| luteolin (CHEBI:15864) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| nintedanib (CHEBI:85164) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| nintedanib esylate (CHEBI:85170) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| orantinib (CHEBI:91088) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| pazopanib (CHEBI:71219) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| pazopanib hydrochloride (CHEBI:71217) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| semaxanib (CHEBI:91083) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| SU1498 (CHEBI:87158) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| SU4312 (CHEBI:92369) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| SU5614 (CHEBI:87159) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| sunitinib (CHEBI:38940) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| telatinib (CHEBI:231351) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| tivozanib (CHEBI:91327) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| vatalanib (CHEBI:90620) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| vatalanib succinate (CHEBI:90623) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| ZM 323881 (CHEBI:91185) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| ZM 323881 hydrochloride (CHEBI:91182) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
